Get 40% Off
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas toolCopy Portfolios

Bird flu testing shows more dairy products are safe, US FDA says

Published 05/01/2024, 01:09 PM
Updated 05/01/2024, 02:42 PM
© Reuters. FILE PHOTO: A person holds a test tube labelled "Bird Flu", in this picture illustration, January 14, 2023. REUTERS/Dado Ruvic/Illustration/File Photo
BCRX
-

By Julie Steenhuysen and Tom Polansek

CHICAGO (Reuters) -Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

The FDA released further test results on foods including sour cream and cottage cheese, after reporting last week that preliminary results from testing showed pasteurization kills the H5N1 virus in milk and baby formula.

The U.S. Department of Agriculture (USDA) has confirmed bird flu in 36 dairy herds in nine states since the first-ever detection in late March, though scientists have said the outbreak is likely more widespread based on findings of H5N1 particles in about 20% of milk samples. One Texas dairy worker tested positive for the virus.

The USDA believes the virus is spreading among cattle primarily through contact with raw milk, Rosemary Sifford, the agency's chief veterinary officer, said on a call that also included officials from the FDA and U.S. Centers for Disease Control and Prevention (CDC). Cows shed the virus at high concentrations in milk, the USDA said.

The FDA so far has tested 297 total retail samples of pasteurized dairy products, and the results released on Wednesday represent tests on 201 of those samples.

"It is a pretty good body of results," Donald Prater, acting director of the FDA's Center for Food Safety and Applied Nutrition, said on the call. "There are probably a few more products that we would look at just so that we make sure that we've got a good national sample."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Scientists are on alert for changes in H5N1 that could signal the virus is adapting to spread easily among humans. The virus has caused serious or fatal infections among people in close contact with wild birds or poultry. It has long been on the list of viruses with pandemic potential, and any expansion to a new mammal species is concerning.

CDC official Dr. Demetre Daskalakis said the agency has monitored about 100 people who have been exposed to bird flu, and around 25 people who developed symptoms have been tested. So far, no additional positive cases have been found.

The agency tested a sample of the virus taken from the farm worker who was infected with H5N1 and found that all commercially available antiviral flu treatments are effective against it. The worker's only symptom was conjunctivitis, commonly known as pink eye.

Currently approved antiviral drugs include Roche's Xofluza and Tamiflu as well as a generic version of Tamiflu, GSK's Relenza and BioCryst (NASDAQ:BCRX) Pharmaceuticals' Rapivab.

The CDC said it is working to grow virus from the infected farm worker for additional lab experiments to assess the severity of the illness and transmissibility of the virus.

It said disease monitoring shows no unusual flu activity in people.

The USDA is testing retail samples of ground beef but said results are not yet available. The department has said it is confident the meat supply is safe.

Wild birds that carry the virus appear to be the initial source of infections in dairy cows, according to USDA. Movement of cattle then spread the disease to other herds and subsequently into poultry flocks, the agency said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.